Genetic polymorphisms in oxidative stress pathway genes may contribute to carcinogenesis, disease recurrence, treatment response, and clinical outcomes. We applied a pathway-based approach to determine the effects of multiple single nucleotide polymorphisms (SNPs) within this pathway on clinical outcomes in non-muscle-invasive bladder cancer (NMIBC) patients treated with Bacillus Calmette-Guérin (BCG). We genotyped 276 SNPs in 38 genes and evaluated their associations with clinical outcomes in 421 NMIBC patients. Twenty-eight SNPs were associated with recurrence in the BCG-treated group (P<0.05). Six SNPs, including five in NEIL2 gene from the overall and BCG group remained significantly associated with recurrence after multiple comparison adjustments (q<0.1). Cumulative unfavorable genotype analysis showed that the risk of recurrence increased with increasing number of unfavorable genotypes. In the analysis of risk factors associated with progression to disease, rs3890995 in UNG, remained significant after adjustment for multiple comparison (q<0.1). These results support the hypothesis that genetic variations in host oxidative stress genes in NMIBC patients may affect response to therapy with BCG.
References
[1]
Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin.
[2]
Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A (2008) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54: 303.314
[3]
Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 49. : 466–465; discussion 475–467.
[4]
van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG (2009) Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 56: 430.442
[5]
Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41: 523.531
[6]
Valavanidis A, Vlachogianni T, Fiotakis C (2009) 8-hydroxy-2′ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27: 120.139
[7]
Mena S, Ortega A, Estrela JM (2009) Oxidative stress in environmental-induced carcinogenesis. Mutat Res 674: 36.44
[8]
Wellen KE, Thompson CB (2010) Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell 40: 323.332
[9]
Ropolo M, Geroldi A, Degan P, Andreotti V, Zupo S (2006) Accelerated repair and reduced mutagenicity of oxidative DNA damage in human bladder cells expressing the E. coli FPG protein. Int J Cancer 118: 1628.1634
[10]
Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98: 472.482
[11]
Choi JY, Barlow WE, Albain KS, Hong CC, Blanco JG (2009) Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clin Cancer Res 15: 5258.5266
[12]
Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME (2008) Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev 17: 2070.2077
[13]
Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Wu K (2008) Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 29: 2335.2340
[14]
Udler M, Maia AT, Cebrian A, Brown C, Greenberg D (2007) Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol 25: 3015.3023
[15]
Farias-Eisner R, Sherman MP, Aeberhard E, Chaudhuri G (1994) Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci U S A 91: 9407.9411
[16]
Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A (2010) Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res (Phila) 3: 1235.1245
[17]
Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163: 1124.1129
[18]
Yue P, Melamud E, Moult J (2006) SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics 7: 166.
[19]
Chen M, Cassidy A, Gu J, Delclos GL, Zhen F (2009) Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis 30: 2047.2052
[20]
Chiong E, Lee IL, Dadbin A, Sabichi AL, Harris L (2011) Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells. Clin Cancer Res 17: 2863.2873
[21]
Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A (2010) Genetic Variations in the Sonic Hedgehog Pathway Affect Clinical Outcomes in Non-Muscle-Invasive Bladder Cancer. Cancer Prev Res. (Phila).
[22]
Hazra TK, Kow YW, Hatahet Z, Imhoff B, Boldogh I (2002) Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J Biol Chem 277: 30417.30420
[23]
Kinslow CJ, El-Zein RA, Hill CE, Wickliffe JK, Abdel-Rahman SZ (2008) Single nucleotide polymorphisms 5′ upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage. Genes Chromosomes Cancer 47: 923.932
[24]
Kinslow CJ, El-Zein RA, Rondelli CM, Hill CE, Wickliffe JK (2009) Regulatory regions responsive to oxidative stress in the promoter of the human DNA glycosylase gene NEIL2. Mutagenesis.
[25]
Bandaru V, Sunkara S, Wallace SS, Bond JP (2002) A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair (Amst) 1: 517.529
[26]
Pearl LH (2000) Structure and function in the uracil-DNA glycosylase superfamily. Mutat Res 460: 165.181
